1. Stocks
    2. /
  2. Telix Pharmaceuticals (ASX: TLX)
    3. /

Telix Pharmaceuticals (ASX: TLX) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Telix Pharmaceuticals Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Telix Pharmaceuticals (ASX: TLX)
    Latest News

    A woman with strawberry blonde hair has a huge smile on her face and fist pumps the air having seen good news on her phone.
    Growth Shares

    These ASX innovators could be the market's next big winners

    | James Mickleboro

    Analysts think these exciting shares could be top buys.

    Read more »

    The words short selling in red against a black background
    Share Market News

    These are the 10 most shorted ASX shares

    | James Mickleboro

    Let's see which shares short sellers are targeting this week.

    Read more »

    A laughing woman wearing a bright yellow suit, black glasses, and a black hat spins dollar bills out of her hands, reflecting dividend earnings.
    Growth Shares

    Build significant wealth with these ASX growth shares over the next 10 years

    | James Mickleboro

    If you are willing to be patient, you could be rewarded handsomely.

    Read more »

    a man holds his arms out and shrugs his shoulders as if indicating he doesn't know the answer to a question he's been asked.
    Share Market News

    These are the 10 most shorted ASX shares

    | James Mickleboro

    Let's see which shares short sellers are targeting this week.

    Read more »

    Man with a hand on his head looks at a red stock market chart showing a falling share price.
    Share Fallers

    Why Rox Resources, Telix, TPG Telecom, and Xero shares are dropping today

    | James Mickleboro

    These shares are ending the week in the red. But why?

    Read more »

    Scientists working in the laboratory and examining results.
    Healthcare Shares

    Why are Telix Pharmaceuticals shares diving today?

    | Cameron England

    Shares in this up-and-coming drug company are under pressure over law suits filed in the US.

    Read more »

    A bearded man holds both arms up diagonally and points with his index fingers to the sky with a thrilled look on his face over these rising Tassal share price
    Growth Shares

    These top ASX 200 shares could rise 50% to 80%

    | James Mickleboro

    Analysts are predicting these shares to deliver huge returns over the next 12 months.

    Read more »

    A worried man holds his head and look at his computer.
    Share Market News

    These are the 10 most shorted ASX shares

    | James Mickleboro

    Let's see which shares short sellers are targeting this week.

    Read more »

    A team of people giving the thumbs up sign.
    Broker Notes

    7 ASX 200 shares upgraded to strong buy ratings

    | Bronwyn Allen

    Looking for investment inspiration?

    Read more »

    Concept image of a businessman riding a bull on an upwards arrow.
    Technology Shares

    Watch out: These 2 ASX 200 shares could soar over 80%

    | Samantha Menzies

    Analysts think these shares will storm higher.

    Read more »

    A young well-dressed couple at a luxury resort celebrate successful life choices.
    Growth Shares

    3 Australian shares that could turn $20,000 into $200,000

    | James Mickleboro

    Analysts think shares could be destined for big things in the future.

    Read more »

    Arrows pointing upwards with a man pointing his finger at one.
    Healthcare Shares

    Why Telix shares could rise almost 40%

    | James Mickleboro

    One leading broker thinks this stock could be a cheap buy at current levels.

    Read more »

    Frequently Asked Questions

    No, Telix does not pay dividends at this time. 

    Telix Pharmaceuticals Ltd listed on the ASX on 15 November 2017.

    TLX ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Telix Pharmaceuticals

    Telix Pharmaceuticals Ltd (ASX: TLX) is a commercial-stage biopharmaceutical company focused on the ongoing development of diagnostic and therapeutic ('theranostic') products using targeted radiation. This process treats cancerous or diseased cells, an alternative approach to many cancer therapies which also attack healthy tissue at the same time.

    Telix has received global regulatory approvals from the Australian Therapeutic Goods Administration (TGA), the US Food and Drug Administration (FDA), and Health Canada for its prostate cancer imaging agent Illuccix. It is working to get Illuccix approved for sale in the UK and Europe. 

    The company also has more than 20 clinical trials underway worldwide. Telix's research and development is focused on prostate, renal (kidney), glioblastoma (brain), and hematologic (bone marrow conditioning) cancers, as well as rare diseases. The company is headquartered in Australia with offices in Belgium, Japan, Switzerland, and the United States. 

    Profile

    since

    Note